top of page
MEDSCI315
NUTRITION, DIET AND GENE INTERACTIONS

Course Breakdown

Internal assessments (50% of total)

  • Mid-semester test - 15%

  • Presentation - 10%

  • Laboratories - 20%

  • Assignments - 10%

Final examination - 45%

Course Information

Basic information:

Date: Semester 1

Location: Grafton (Lectures and Labs)

Prerequisites: must have completed 1 of BIOSCI 202 or BIOSCI 203

Official UOA course curriculum: link.

Course Contacts:

Course co-ordinator

Chris Hedges (c.hedges@auckland.ac.nz)

Basic Information

 

This course looks at the intersection of genetics and nutrition, explored through the lenses of cellular signalling, epigenetics, and population-level disease risk. You'll come across concepts ranging from how your diet can switch genes on and off, the role of the gut microbiome in shaping your response to what you eat, and why two people can follow the same diet with completely different outcomes. Learning about the molecular mechanisms behind conditions like obesity, type 2 diabetes, and Crohn's disease alongside the 'omics' technologies used to study them gives a unique flavour of what it's like to work at the cutting edge of personalised nutrition and medicine.

 

MEDSCI 315 sits at a moderate content density for a Stage 3 MEDSCI paper, covering a broad range of topics from nutrigenomics to bone health supplements to flavour perception. This breadth means that while no single topic is overwhelming, keeping on top of the material consistently throughout the semester is key, especially given that the final exam carries a hefty 45% of your grade (although open book in 2025) and requires a genuine pass of at least 22.5% to avoid failing the course regardless of your internal marks.

 

The assessment structure in 2025 consisted of a final exam (45%), laboratories (20%), a mid-semester test (15%), a group presentation (10%), and individual assignments (10%). The group presentation pairs you with a partner to communicate gene-diet interaction concepts, and with adequate preparation it's a very manageable way to pick up marks. Worth noting is that internal assessments also carry a combined pass threshold of 27.5% out of 55%, so keeping up with the test and assignments matters.

The course is delivered through a mix of lectures, tutorials, and lab practicals, and was regarded by students as well-organised relative to other Stage 3 MEDSCI offerings, making for a smooth experience on both sides of the classroom.

Overview


MEDSCI 315 is an open book Stage 3 MEDSCI paper, but don't let that fool you, as the open book format offers less of an advantage than you might expect, and a number of students found it more damaging to their GPA than some closed book papers.

 

Lectures cover how genes interact with diet to influence the risk of conditions like diabetes, obesity, cancer, and poor bone health, with an additional three lectures dedicated to the microbiome. The content itself is fairly accessible, but a notable portion of lecture time is spent walking through study results and interpreting data on the fly. Students have noted that having clearer takeaway points on slides, rather than live data interpretation, would make this time more efficient.

 

The labs themselves are among the more relaxed practical sessions you'll encounter at Stage III, but the lab report marking is where things get tricky. With the report marked out of just 20, the margin for error is extremely thin, where losing even two marks drops you below an A+, and losing three or four marks pulls you down further still. A significant source of frustration for students in 2025 was that feedback on the lab report was withheld in favour of faster turnaround on results, leaving those who lost marks with no understanding of where they went wrong.

 

The mid-semester test is generally considered the most straightforward component. It consists of MCQ questions with justification and a couple of medium-length answers, and is widely regarded as the component most likely to support your grade.

 

Assignments are where many students found themselves losing marks unexpectedly. The critical review assignment is marked out of 20, and because it's a nuanced task, missing just a few specific points the marker is looking for can make the difference between an A+ and an A or lower. Students reported that the guidance given beforehand did not always align with the feedback received afterward, which made it difficult to know what was expected. The brochure and presentation assignment, on the other hand, is much more forgiving, if you keep your slides minimal, your word count low, and your delivery confident and audience-facing, and it's very achievable to score well.

 

The final exam requires some lateral and connective thinking. Rather than simply recalling what you were taught about a given gene variant and its associated disease, you may be asked to connect a variant to a disease outside of what was explicitly covered in lectures, so building an understanding of how different variants interrelate is important exam preparation. There was also some uncertainty in 2025 around which modules would be assessed, with students reporting that content they were told would not be a focus appeared in the exam regardless.

 

Overall, MEDSCI 315 is a course with genuinely interesting ideas at its core, particularly the way seemingly unrelated genetic variants turn out to be linked, but the assessment structure, with several components marked out of small totals and limited feedback in places, means that GPA outcomes can feel difficult to predict or control. Students considering this course should go in with realistic expectations about the open book format and pay close attention to assessment criteria from the outset.

bottom of page